43.29MMarket Cap-2975P/E (TTM)
1.550High0.910Low5.25MVolume0.940Open0.970Pre Close6.59MTurnover49.58%Turnover RatioLossP/E (Static)36.38MShares5.62052wk High5.09P/B12.61MFloat Cap0.81052wk Low--Dividend TTM10.60MShs Float33.000Historical High--Div YieldTTM65.95%Amplitude0.810Historical Low1.253Avg Price1Lot Size
Estrella Immunopharma Stock Forum
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
Estrella Immunopharma, Inc. (NASDAQ:ESLA, ESLAW))) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that the first patient enrolled in its STARLIGHT-1 Phase I/II clinical trial has achieved a complete respons...
It has good potential for holding long term.
Buy more for the dip, and hold it long😄
This guy has been sleeping too long already 🤣🤣🤣
No comment yet